Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adenocarcinoma of the Esophagogastric Junction
100%
Esophagectomy
100%
Total Gastrectomy
100%
Registry-based
100%
Gastrectomy
42%
5-year Survival
28%
Randomized Controlled Trial
14%
Confidence Interval
14%
Hazard Ratio
14%
Overall Survival
14%
Adenocarcinoma
14%
Population-based Study
14%
Adjusted Analysis
14%
Result Comparison
14%
Length of Stay
14%
Reduced Survival
14%
Gastroesophageal Junction Cancer
14%
Multivariable
14%
Positive Lymph Nodes
14%
Population-based Cohort Study
14%
Surgical Approach
14%
Prognostic Outcome
14%
Surgical Strategy
14%
Low Burden
14%
National Cancer Database
14%
90-day Mortality
14%
Lymph Node Harvest
14%
Propensity Score Matching
14%
Treatment Selection Bias
14%
Propensity Matching
14%
Medical Comorbidity
14%
Surgical Quality Assurance
14%
Medicine and Dentistry
Adenocarcinoma
100%
Esophagectomy
100%
Total Stomach Resection
100%
Gastroesophageal Junction
100%
Gastrectomy
42%
Malignant Neoplasm
28%
Lymph Node
28%
Comorbidity
14%
Hazard Ratio
14%
Overall Survival
14%
Randomized Controlled Trial
14%
Cohort Analysis
14%
Population Research
14%
Selection Bias
14%
Surgical Approach
14%
Propensity Score Matching
14%